Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-15 | New | $32,289,627 | $32,289,627 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Scott David Lyman | Director, Executive |
| David Algon Neal | Director, Executive |
| Wes Wheeler | Director |
| Derek Winstanly | Director |